查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574758

Deslanoside 市场：按产品类型、应用、最终用户、分销管道划分 - 全球预测 2025-2030

Deslanoside Market by Product Type (Purity Level), Application (Pharmaceuticals, Research Institutes), End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年Deslanoside市值为954.8亿美元，预计到2024年将达到995.6亿美元，复合年增长率为5.65%，到2030年将达到1403.5亿美元。

Deslanoside 是一种强心配糖体，主要用于医疗应用，治疗心房颤动和心臟衰竭等心臟疾病。需要deslanoside是因为它具有加强心臟收缩和控制心率的作用，使其成为循环系统的重要药物。当其他治疗无效或有禁忌时也可使用它。最终用途范围主要包括世界各地的医院、诊所和心臟专科中心，用作心臟病患者各种治疗方法的一部分。

主要市场统计
基准年[2023] 954.8亿美元
预测年份 [2024] 995.6亿美元
预测年份 [2030] 1403.5亿美元
复合年增长率（%） 5.65%

根据市场洞察，心血管疾病盛行率的增加以及人口老化的加剧（更容易患心臟病）推动了对deslanoside的需求。此外，新药物传递机制和配方的开发可能会扩大治疗应用并提高患者依从性，从而带来潜在的成长机会。随着全球医疗保健系统向先进的心臟治疗迈进，脱氢菊苷的市场可能会稳定成长。然而，严格的监管要求、潜在副作用以及替代心臟治疗的竞争等挑战可能会阻碍市场成长。此外，与心臟治疗相关的高成本可能会限製成本敏感地区的采用。

为了抓住新的商机，鼓励相关人员集中精力进行大规模临床试验，以证明新配方的有效性和安全性。此外，技术创新可用于开发具有成本效益的生产工艺，以提高新兴市场药品的可用性和可负担性。旨在改进强心配糖体配方、将副作用降至最低的合作研究工作可以使产品脱颖而出，并对市场动态产生正面影响。芥花苷市场的特点是在医疗需求的推动下具有适度增长的潜力，但受到监管和经济因素的挑战。相关人员应重点平衡创新与成本和监管合规性，以实现永续成长。

市场动态：揭示快速发展的 Deslanoside 市场的关键市场洞察

供需的动态交互作用正在改变芥花苷市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 在个人化医疗方法中使用 deslanoside 进行客製化的心臟治疗
    • 转向微创心臟治疗增加了 deslanoside 的采用
    • 学术界和工业界在deslanoside研究方面的合作研究计划
    • 增加针对医疗保健专业人员的 deslanoside 使用教育计划
  • 市场限制因素
    • 严格的监管指南和与药物核准相关的高成本导致市场成长缓慢
    • 原料供应有限，导致脱氢菊苷市场面临生产挑战与供应链中断
  • 市场机会
    • deslanoside 在心臟治疗和管理的创新治疗应用
    • deslanoside在个人化医疗和标靶治疗领域的新商机
    • 扩大deslanoside在兽医心臟医学的应用
  • 市场挑战
    • 医疗保健专业人员对 deslanoside 的用途和益处的认识和理解有限
    • 由于激烈的竞争和市场整合，新进入者进入 deslanoside 市场的机会有限

波特的五力：驾驭 Deslanoside 市场的策略工具

波特的五力框架是了解 Deslanoside 市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对 Deslanoside 市场的外部影响

外部宏观环境因素在塑造 Deslanoside 市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解deslanoside市场的竞争状况

对 Deslanoside 市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 Deslanoside 市场供应商的绩效评估

FPNV定位矩阵是评估Deslanoside市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 Deslanoside 市场的成功之路

对于想要加强在全球市场的影响力的公司来说，Deslanoside 市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 透过在个人化医疗方法中使用 deslanoside 来客製化心臟病治疗
      • 转向微创心臟治疗增加了 deslanoside 的采用
      • 脱氢菊苷研究的产学合作研究成果
      • 增加对医护人员使用 deslanoside 的教育计划
    • 抑制因素
      • 严格的监管指南和与药物核准相关的高成本正在减缓市场成长
      • 原材料供不应求正在造成生产挑战并扰乱供应链。芥花苷市场
    • 机会
      • deslanoside 在心臟治疗和管理的创新治疗应用
      • deslanoside在个人化医疗和标靶治疗中的新机会
      • 扩大 deslanoside 在兽药中的使用，以促进动物心臟健康
    • 任务
      • 医疗保健专业人员对 deslanoside 的用途和益处的认识和理解有限
      • 激烈的竞争和市场整合限制了新进入的机会。芥花苷市场
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 Deslanoside 市场：依产品类型

  • 纯度等级
    • 纯度98%以上
    • 纯度小于98%

第七章 Deslanoside 市场：依应用分类

  • 药品
    • 心血管疾病
  • 调查机构

第 8 章 Deslanoside 市场：依最终使用者分类

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 调查机构

第九章 Deslanoside 市场：依通路

  • 医院药房
  • 网路药房
  • 零售药房

第10章 美洲Deslanoside市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区芥花苷市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0475

The Deslanoside Market was valued at USD 95.48 billion in 2023, expected to reach USD 99.56 billion in 2024, and is projected to grow at a CAGR of 5.65%, to USD 140.35 billion by 2030.

Deslanoside is a cardiac glycoside primarily utilized in medical applications for the treatment of heart conditions such as atrial fibrillation and heart failure. The necessity for Deslanoside arises from its effectiveness in strengthening heart contractions and controlling heart rate, making it an essential drug in cardiology. Its application extends to being used in cases where other treatments might be ineffective or contraindicated. The end-use scope predominantly includes hospitals, clinics, and specialized cardiac centers worldwide, where it serves as part of the broader therapeutic regimen for heart patients.

KEY MARKET STATISTICS
Base Year [2023] USD 95.48 billion
Estimated Year [2024] USD 99.56 billion
Forecast Year [2030] USD 140.35 billion
CAGR (%) 5.65%

Market insights indicate that the demand for Deslanoside is driven by the increasing prevalence of cardiovascular diseases and the growing aging population, who are more vulnerable to cardiac issues. Furthermore, the development of new drug delivery mechanisms and formulations may expand its therapeutic use and improve patient compliance, offering potential growth opportunities. As healthcare systems globally move towards advanced cardiac care, Deslanoside's market may witness a steady rise. However, challenges such as stringent regulatory requirements, potential side effects, and competition from alternative cardiac therapies could hinder market growth. Additionally, the high costs associated with cardiac treatments could limit widespread adoption in cost-sensitive regions.

To tap into the emerging opportunities, it is recommended that stakeholders focus on conducting extensive clinical trials to demonstrate the efficacy and safety of new Deslanoside formulations. Additionally, innovation could be directed towards developing cost-effective production processes, increasing the accessibility and affordability of the drug in developing markets. Collaborative research efforts for improved cardiac glycoside formulations with minimal side effects could differentiate products and influence market dynamics positively. The nature of the Deslanoside market is characterized by moderate growth potential, driven by medical necessity but challenged by regulatory and economic factors. Stakeholders should focus on balancing innovation with cost and regulatory compliance to achieve sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Deslanoside Market

The Deslanoside Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Adoption of Deslanoside in personalized medicine approaches for tailored cardiac therapy
    • Shift towards minimally invasive cardiac treatments increasing Deslanoside adoption
    • Collaborative research initiatives between academia and industry in Deslanoside studies
    • Rising number of educational programs for healthcare professionals on Deslanoside usage
  • Market Restraints
    • Stringent regulatory guidelines and high costs associated with drug approvals leading to slower market growth
    • Limited availability of raw materials resulting in production challenges and supply chain disruptions in the deslanoside market
  • Market Opportunities
    • Innovative therapeutic applications of deslanoside in cardiac treatment and management
    • Emerging opportunities for deslanoside in personalized medicine and targeted therapies
    • Expansion of deslanoside use in veterinary medicine for animal cardiac health
  • Market Challenges
    • Limited awareness and understanding among healthcare professionals regarding Deslanoside usage and benefits
    • Intense competition and market consolidation limiting opportunities for new entrants in the Deslanoside market

Porter's Five Forces: A Strategic Tool for Navigating the Deslanoside Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Deslanoside Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Deslanoside Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Deslanoside Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Deslanoside Market

A detailed market share analysis in the Deslanoside Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Deslanoside Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Deslanoside Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Deslanoside Market

A strategic analysis of the Deslanoside Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Deslanoside Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Cardinal Health, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Medtronic, Merck & Co., Mylan N.V., Novartis AG, Novo Nordisk, Pfizer Inc., Roche Holding AG, Sanofi, and Teva Pharmaceutical Industries.

Market Segmentation & Coverage

This research report categorizes the Deslanoside Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Purity Level. The Purity Level is further studied across Greater Than 98% Pure and Less Than 98% Pure.
  • Based on Application, market is studied across Pharmaceuticals and Research Institutes. The Pharmaceuticals is further studied across Cardiovascular Diseases.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Research Institutes. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Adoption of Deslanoside in personalized medicine approaches for tailored cardiac therapy
      • 5.1.1.2. Shift towards minimally invasive cardiac treatments increasing Deslanoside adoption
      • 5.1.1.3. Collaborative research initiatives between academia and industry in Deslanoside studies
      • 5.1.1.4. Rising number of educational programs for healthcare professionals on Deslanoside usage
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory guidelines and high costs associated with drug approvals leading to slower market growth
      • 5.1.2.2. Limited availability of raw materials resulting in production challenges and supply chain disruptions in the deslanoside market
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative therapeutic applications of deslanoside in cardiac treatment and management
      • 5.1.3.2. Emerging opportunities for deslanoside in personalized medicine and targeted therapies
      • 5.1.3.3. Expansion of deslanoside use in veterinary medicine for animal cardiac health
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and understanding among healthcare professionals regarding Deslanoside usage and benefits
      • 5.1.4.2. Intense competition and market consolidation limiting opportunities for new entrants in the Deslanoside market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Deslanoside Market, by Product Type

  • 6.1. Introduction
  • 6.2. Purity Level
    • 6.2.1. Greater Than 98% Pure
    • 6.2.2. Less Than 98% Pure

7. Deslanoside Market, by Application

  • 7.1. Introduction
  • 7.2. Pharmaceuticals
    • 7.2.1. Cardiovascular Diseases
  • 7.3. Research Institutes

8. Deslanoside Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
    • 8.3.1. Private Hospitals
    • 8.3.2. Public Hospitals
  • 8.4. Research Institutes

9. Deslanoside Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacy
  • 9.3. Online Pharmacy
  • 9.4. Retail Pharmacy

10. Americas Deslanoside Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Deslanoside Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Deslanoside Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen Inc.
  • 3. AstraZeneca
  • 4. Bayer AG
  • 5. Boehringer Ingelheim
  • 6. Bristol-Myers Squibb
  • 7. Cardinal Health
  • 8. Eli Lilly and Company
  • 9. Gilead Sciences
  • 10. GlaxoSmithKline
  • 11. Johnson & Johnson
  • 12. Medtronic
  • 13. Merck & Co.
  • 14. Mylan N.V.
  • 15. Novartis AG
  • 16. Novo Nordisk
  • 17. Pfizer Inc.
  • 18. Roche Holding AG
  • 19. Sanofi
  • 20. Teva Pharmaceutical Industries

LIST OF FIGURES

  • FIGURE 1. DESLANOSIDE MARKET RESEARCH PROCESS
  • FIGURE 2. DESLANOSIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DESLANOSIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DESLANOSIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DESLANOSIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DESLANOSIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DESLANOSIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DESLANOSIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DESLANOSIDE MARKET SIZE, BY GREATER THAN 98% PURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DESLANOSIDE MARKET SIZE, BY LESS THAN 98% PURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DESLANOSIDE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DESLANOSIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DESLANOSIDE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DESLANOSIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DESLANOSIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DESLANOSIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DESLANOSIDE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DESLANOSIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DESLANOSIDE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES DESLANOSIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA DESLANOSIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 174. DENMARK DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. EGYPT DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 181. EGYPT DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. FINLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. FINLAND DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 188. FINLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. FRANCE DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FRANCE DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 195. FRANCE DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. GERMANY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. GERMANY DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 202. GERMANY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. ISRAEL DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. ISRAEL DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 209. ISRAEL DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. ITALY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ITALY DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 216. ITALY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. NIGERIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NIGERIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 230. NIGERIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. NORWAY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NORWAY DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 237. NORWAY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. POLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. POLAND DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 244. POLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. QATAR DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. QATAR DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 251. QATAR DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 256. RUSSIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. RUSSIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 258. RUSSIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. SPAIN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SPAIN DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 279. SPAIN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. SWEDEN DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SWEDEN DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 286. SWEDEN DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 291. SWITZERLAND DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWITZERLAND DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 293. SWITZERLAND DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. TURKEY DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. TURKEY DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 300. TURKEY DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 307. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM DESLANOSIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 319. DESLANOSIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 320. DESLANOSIDE MARKET, FPNV POSITIONING MATRIX, 2023